Who makes LEISH-F3 alone?

LEISH-F3 alone is developed by Access to Advanced Health Institute (AAHI).

Last reviewed 2026-04-20 · How we verify

LEISH-F3 alone

Access to Advanced Health Institute (AAHI) · Phase 1 active Biologic Quality 0/100

At a glance

Generic name	LEISH-F3 alone
Sponsor	Access to Advanced Health Institute (AAHI)
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

LEISH-F3 alone CI brief — competitive landscape report
LEISH-F3 alone updates RSS · CI watch RSS
Access to Advanced Health Institute (AAHI) portfolio CI